Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

181-192 of 375 results
Page 16 of 32
Key Publications January 8, 2016

The endocannabinoid system: pivotal orchestrator of obesity and metabolic disease.

Trends Endocrinol Metab. 2015;26:524-37

Mazier W, Saucisse N, Gatta-Cherifi B, Cota D
Metabolism Nutrition Obesity
Key Publications December 24, 2015

PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future.

Eur Heart J. 2015;36:2415-24

Shimada YJ, Cannon CP
Lipids/Lipoproteins Metabolism
Expert Opinions December 23, 2015

What evidence do we have that the brown adipose tissue could play an important role in energy balance in human?

André Carpentier, MD, Department of Medicine, Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Université de Sherbrooke, Québec, Canada
Adipose Tissue Diabetes Metabolism
Key Publications December 23, 2015

Cardiovascular risks and benefits of moderate and heavy alcohol consumption.

Nat Rev Cardiol. 2015;12:576-87

Fernández-Solà J
Cardiovascular Disease Metabolism Nutrition
Key Publications November 6, 2015

The metabolome profiling and pathway analysis in metabolic healthy and abnormal obesity.

Int J Obes (Lond). 2015;39:1241-8

Chen HH, Tseng YJ, Wang SY, Tsai YS, Chang CS, Kuo TC, Yao WJ, Shieh CC, Wu CH, Kuo PH
Metabolic Syndrome Metabolism Obesity
Key Publications November 5, 2015

Physiological adaptations to weight loss and factors favouring weight regain.

Int J Obes (Lond). 2015;39:1188-96

Greenway FL
Metabolism Obesity Weight Loss
Key Publications November 4, 2015

Is cholesteryl ester transfer protein inhibition an effective strategy to reduce cardiovascular risk? CETP inhibition as a strategy to reduce cardiovascular risk: the pro case.

Circulation. 2015;132:423-32

Barter PJ, Nicholls SJ, Kastelein JJ, Rye KA
Cardiovascular Disease Lipids/Lipoproteins Metabolism
Key Publications November 4, 2015

Is cholesteryl ester transfer protein inhibition an effective strategy to reduce cardiovascular risk? CETP as a target to lower CVD risk: suspension of disbelief?

Circulation. 2015;132:433-40

Hovingh GK, Ray KK, Boekholdt SM
Cardiovascular Disease Lipids/Lipoproteins Metabolism
Key Publications October 30, 2015

Usefulness of B-type natriuretic peptides to predict cardiovascular events in women (from the Women's Health Study).

Am J Cardiol. 2015;116:532-7

Everett BM, Ridker PM, Cook NR, Pradhan AD
Cardiometabolic Risk Cardiovascular Disease Metabolism
Key Publications October 22, 2015

Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans.

Atherosclerosis. 2015;241:326-33

Desai NK, Ooi EM, Mitchell PD, Furtado J, Sacks FM
Lipids/Lipoproteins Metabolism Metabolism: Human Studies
Key Publications October 20, 2015

Unraveling the environmental and genetic interactions in atherosclerosis: Central role of the gut microbiota.

Atherosclerosis. 2015;241:387-99

Org E, Mehrabian M, Lusis AJ
Genetics Inflammation Metabolism
Key Publications September 23, 2015

Nutritional impact of sodium reduction strategies on sodium intake from processed foods.

Eur J Clin Nutr. 2015;69:805-10

Hendriksen MA, Verkaik-Kloosterman J, Noort MW, van Raaij JM
Epidemiology Metabolism Nutrition
of 32